An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment
An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment
复制标题
二甲双胍联合治疗接受雄激素剥夺治疗的前列腺癌患者的开放标签试点研究
DOI:
10.1159/000448691
复制
发表时间:
2016-09
期刊:
影响因子:
--
通讯作者:
Jiang H
中科院分区:
文献类型:
--
作者:
Zhu W;Xu H;Ma J;Guo J;Xue W;Gu B;Sheng L;Yao X;Sun F;Gong J;Qiu W;Ding Q;Jiang H
Purpose: The study aimed to evaluate the effects of metformin on insulin, C-peptide and body weight in Chinese men undergoing androgen deprivation therapy (ADT). Methods: Between March 2013 and June 2014, 62 newly diagnosed patients of prostate cancer (PCa) due to receive ADT were recruited from 7 hospitals in Shanghai. Patients were randomized to respectively receive ADT (n = 31) and ADT + metformin (n = 31) for 6 months. Fasting and postprandial serum levels of insulin and C-peptide, blood glucose, prostate specific antigen, body mass index (BMI) and waist circumference (WC) were measured at the beginning and end of 6-month treatment. Results: Baseline characteristics were comparable between the 2 groups. Controlling for baseline levels, the ADT group had significantly higher levels of fasting glucose (p = 0.01) and higher WC (p = 0.04) than the ADT + metformin group. The levels of insulin, C-peptide and BMI did not differ significantly. Conclusions: Metformin may be potentially efficient as a concomitant therapy on patients with PCa undergoing androgen deprivation treatment.
登录
查看更多内容
影响因子:
1
作者:
R. Barbieri;A. Gargiulo
通讯作者:
R. Barbieri;A. Gargiulo
影响因子:
10.3
作者:
Hsing, AW;Chua, S;Stanczyk, FZ
通讯作者:
Stanczyk, FZ
影响因子:
2.8
作者:
Cox, Michael E.;Gleave, Martin E.;Pollak, Michael
通讯作者:
Pollak, Michael
影响因子:
2.3
作者:
Wright, Jonathan L.;Stanford, Janet L.
通讯作者:
Stanford, Janet L.
影响因子:
158.5
作者:
STUMVOLL, M;NURJHAN, N;GERICH, JE
通讯作者:
GERICH, JE